Multiple Intervention and AUdit in Renal Diseases to Optimize Care (MAURO)
|ClinicalTrials.gov Identifier: NCT00566033|
Recruitment Status : Completed
First Posted : November 30, 2007
Last Update Posted : January 31, 2012
Test whether the intensive intervention improves renal and cardiovascular outcomes in patients with chronic renal insufficiency.
Test whether a multi-method intensive intervention including clinical Audit improves adherence to a series of quality indicators relevant to hypertension control, proteinuria, treatment of dyslipidemia, anemia, calcium and phosphate alterations in patients with chronic renal insufficiency.
|Condition or disease||Intervention/treatment||Phase|
|Renal Insufficiency||Behavioral: Audit-driven intervention||Phase 4|
Show Detailed Description
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||788 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Care Provider)|
|Official Title:||Multiple Intervention and AUdit in Renal Diseases to Optimize Care: the MAURO Study.|
|Study Start Date :||January 2006|
|Primary Completion Date :||August 2011|
|Study Completion Date :||August 2011|
Behavioral: Audit-driven intervention
Patients included in this arm will undergo to the multi-method quality improvement intervention (intensive intervention) that adds practice visits, telephone and e-mail contacts (for quality improvement facilitation) and audits to the approach of periodic guideline dissemination and feedback on demand used in the less intensive intervention.
No Intervention: 2
Patients in this arm (arm 2) will undergo to standard care.
- A composite renal and cardiovascular (CV) end point, i.e. >30% decrease in the GFR, dialysis, transplantation, death or CV event. [ Time Frame: 3 years ]
- The primary renal unit-level outcome is the percentage of performance targets achieved. The primary patient-level outcome is the percentage of patients for whom the recommended process measures occurs. [ Time Frame: 3 years ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00566033
|Nephrology Units participating to the MAURO study in the|
|Calabrian, Sicily, Puglia and Sardenia Regions, Italy|
|Study Director:||Carmine Zoccali, Prof.||CNR-IBIM & Nephrology Unit of Reggio Calabria|